Abstract
With the recent publication of the human genome sequence, there has been an expanse of publicly available resources for pharmacogenomics research. Early estimates predicted that over 3 million single nucleotide polymorphisms (SNPs) are present in the human genome, with over 1.42 million already deposited in the public databases (1). SNPs in coding and control regions of genes can cause significant inter-individual variation in the resulting protein function and activity, leading to important differences in disease susceptibility and drug metabolism. This expansion in valuable SNPs has stimulated the development of a number of detection methods (2). We describe protocols for three distinct methods (allele-specific polymerase chain reaction (PCR), PCR-restriction fragment length polymorphism (PCR-RFLP), and Pyrosequencing) as examples of ways to assay clinically relevant polymorphisms.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
The International SNP Map Working Group (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933.
Kwok, P. Y. (2001) Methods for genotyping single nucleotide polymorphisms. Annu. Rev. Genomics Hum. Genet. 2, 235–258.
Krynetski, E.Y., Tai, H-L., Yates, C.R., et al. (1996) Genetic polymorphism of thiopurine methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 6, 279–290.
Weinshilboum, R. (2001) Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab. Dispos. 29, 601–605.
McLeod, H. L., Krynetski, E. Y., Relling, M. V., and Evans, W. E. (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14, 567–572.
Ameyaw, M. M., Collie-Duguid, E. S., Powrie, R. H., Ofori-Adjei, D., and McLeod, H. L. (1999) Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum. Mol. Genet. 8, 367–370.
Hon, Y. Y., Fessing, M. Y., Pui, C. H., Relling, M. V., Krynetski, E. Y., and Evans, W. E. (1999) Polymorphism of the thiopurine S-methyltransferase (TPMT) gene in African Americans. Hum. Mol. Genet. 8, 371–376.
McLeod, H. L., Coulthard, S., Thomas, A. E., et al. (1999) Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukemia. Br. J. Haematol. 105, 696–700.
Ronaghi, M. (2001) Pyrosequencing sheds light on DNA sequencing. Genome Res. 11, 3–11.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Rose, C.M., Marsh, S., Ameyaw, MM., McLeod, H.L. (2003). Pharmacogenetic Analysis of Clinically Relevant Genetic Polymorphisms. In: Buolamwini, J.K., Adjei, A.A. (eds) Novel Anticancer Drug Protocols. Methods in Molecular Medicine, vol 85. Humana Press. https://doi.org/10.1385/1-59259-380-1:225
Download citation
DOI: https://doi.org/10.1385/1-59259-380-1:225
Publisher Name: Humana Press
Print ISBN: 978-0-89603-963-6
Online ISBN: 978-1-59259-380-4
eBook Packages: Springer Protocols